Polycystic ovary syndrome is now called polyendocrine metabolic ovarian syndrome, or PMOS. The new name was published in The Lancet on May 12, 2026, after a global process led by Monash University. It is the same condition with a more accurate name. Here is what the name means, why it changed, and what it changes for you (not much, yet).
| Word | What it points to |
|---|---|
| Polyendocrine | Several hormone systems are involved, not just the ovaries. High androgens such as testosterone are one example. |
| Metabolic | Insulin resistance, weight and the higher risk of type 2 diabetes that come with the condition. |
| Ovarian | Irregular ovulation and periods, and the ovary changes seen on a scan. |
| Syndrome | A group of features that show up together, so not everyone has all of them. |
The paper says the old name was inaccurate. "Polycystic" suggests harmful cysts on the ovaries, which is not what the condition is. Monash Health, which led the work, puts it plainly: there is no increase in abnormal cysts in the condition. What shows on a scan are many small follicles, which are eggs that have not been released.
The authors also say the old name hid the hormone and metabolic side of the condition, and that this added to late diagnosis, scattered care and stigma. Someone with no "cysts" could be told they did not have PCOS, even with irregular periods and high androgens.
The process involved 56 academic, clinical and patient organisations. Global surveys collected responses from 14,360 people with PCOS and health professionals from every world region, followed by expert voting rounds and workshops. An accurate new name was picked over keeping the PCOS letters or using a generic name.
Not everyone agrees with it. The Lancet published letters debating the new name, and the authors replied in July 2026.
During the transition you will see both names, often side by side. Many doctors, apps and websites, including this one, still say PCOS so people can find what they are looking for.
If you were diagnosed with PCOS, you have PMOS. It is the same condition, so your diagnosis still stands and you do not need new tests.
The Lancet paper is about the name only. The way the condition is diagnosed today still follows the 2023 international guideline: irregular cycles, high androgens, and polycystic ovaries on a scan or a high AMH, with two of the three needed. Our PCOS symptom check walks through those criteria.
PCOS & Endo Tracker logs periods, pain, symptoms, food and blood sugar in about 20 seconds a day, and turns it into a summary for your doctor. Free to log, no account, your data stays on your phone.
No. PMOS is the new name for the same condition. If you have a PCOS diagnosis, you have PMOS.
The old name was misleading. The small "cysts" seen on a scan are follicles, and Monash Health says there is no increase in abnormal cysts in the condition.
The change is planned over 3 years, with the new name expected to be fully built into the 2028 international guideline. Some, like the NHS website, already use it.
No. PMDD is premenstrual dysphoric disorder, a severe form of premenstrual mood symptoms. PMOS is the new name for PCOS.
Polyendocrine metabolic ovarian syndrome: several hormone systems (polyendocrine), insulin and weight (metabolic), and the ovaries (ovarian).
Written by Hicham Zaidi, maker of PCOS & Endo Tracker, from the sources above. General information, not medical advice. Updated November 10, 2026.